Clinical Trial

Epidemiological Study on Invasive Bacterial Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae (hemophilus) are among the main bacteria responsible for invasive bacterial diseases (MBIs) that result in severe clinical pictures also characterized by a high frequency of serious complications. Surveillance of infections caused by these pathogens and their distribution by serotypes/serogroups is essential to guide public health interventions, assess epidemiologic trends, monitor any secondary cases, estimate the proportion of preventable cases, identify any vaccine failures, and evaluate the impact of vaccine strategies.The present study aims to study the epidemiology of invasive bacterial diseases, characterize the circulating strains also in order to plan treatment and prevention strategies.
Trial Details
NCT Number NCT06322290
Lead Sponsor Meyer Children's Hospital IRCCS
Conditions Invasive Bacterial Diseases (IBD)
Enrollment 5,000 participants
Start Date 2021-12-09
Primary Completion 2031-12-30 (estimated)
Study Completion 2032-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-21